The Cabinet of Ministers approved a bill on updating the strategy, which provides for the restoration of war-damaged territories and the integration of EU requirements.
The Kyiv Commercial Court will hear a lawsuit on 16 November seeking to invalidate an investment agreement for the Main Astronomical Observatory site. The investor is LLC "Freds Resorts", whose shares are held by Vladislava Molchanova's sons.
Ukrainian President explained why a new head of the Office of the Prosecutor General has not yet been appointed and responded to accusations made against him by the former head of the department.
Desnyansky District Court is hearing the prosecution's case against Vasyl Bilohura. He is accused of inflating construction material costs during the reconstruction of a gymnasium funded by Swiss grants.
Analytics show that 1,399 documents submitted by 1,012 individuals working for the SBU are hidden from public access. The record is for 2023.
The new Deputy Minister of Digital Transformation, Valeriia Koval, holds a degree in political science and has extensive experience in the digitalisation sector.
Anna Prokop described how two men and a woman surrounded a young Ukrainian in a Żabka store, insulting him and threatening to return after his shift.
A company uniting marine drone experts and investors has appeared in Bucha. Analysis of the ownership structure revealed links to the "Falkor" fund and a discussion regarding the identity of one of the beneficiaries.
A great achievement in ophthalmology: children born blind can now see the world around them.
A group of scientists and doctors from London has achieved a historic breakthrough in treating children with a rare disease that causes total blindness from birth. For the first time, specialists have been able to restore vision in children suffering from congenital amaurosis caused by a mutation in the AIPL1 gene.
This condition, characterised by total loss of vision, was previously considered irreversible. However, thanks to a new technique, doctors implanted healthy copies of the AIPL1 gene into the children's retinas, which significantly improved their visual capabilities.
The treatment process involved implanting genetically corrected cells into the retina, and five years after the operation, the results have not only persisted but continued to improve. The young patients can now recognise their parents' faces, find toys, and read and write. This achievement has opened new horizons in the treatment of hereditary diseases and given hope to many families around the world.
This discovery represents a significant step forward in gene therapy and confirms that medicine can overcome barriers that seemed insurmountable just a few decades ago. The success of the experiment in London offers hope for the treatment of other forms of blindness, as well as a multitude of other genetic diseases previously considered incurable.
Comments
No comments yet. Be the first!